Abstract
This review article discusses the concepts of a tumor microenvironment and a gut microbiome and their effects on responses to checkpoint inhibitors (CPIs). It also reviews recent research investigating these 3 topics, and how it can be applied to using CPIs in prostate cancer.
Original language | English (US) |
---|---|
Journal | ONCOLOGY (United States) |
Volume | 34 |
Issue number | 3 |
State | Published - Mar 19 2020 |
ASJC Scopus subject areas
- Oncology
- Cancer Research